Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition
UEAIVN
Changes in CO2-13/CO2-12 Delta Value in Exhaled Breath to Examine Changes in Metabolism in Patients Being Fed Intravenous Nutrition
1 other identifier
observational
20
1 country
1
Brief Summary
Carbon-12 and carbon-13 are naturally-occurring isotopes that are found in exhaled breath. Investigators have proved that the 13CO2/12CO2 breath delta value (BDV) changes in subjects who were in negative energy balance then fed a positive energy balance meal. Measuring one liter of exhaled breath daily may be a more convenient way to measure negative or positive energy balance in patients receiving intravenous nutrition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2016
CompletedStudy Start
First participant enrolled
June 8, 2016
CompletedFirst Posted
Study publicly available on registry
July 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 10, 2017
CompletedNovember 28, 2017
November 1, 2017
1.1 years
June 6, 2016
November 26, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Variation in Breath Delta Value
Investigators will test if the breath delta value (kJ) increases in subjects from baseline (pre-parenteral nutrition) to the subject's goal calculated rate. The time frame tested for each subject will be from baseline to 7 days or the length of parenteral nutrition (whichever is shorter.) Investigators will recruit 20 patients, and this may take 6 months to accomplish. This is a pilot investigation.
baseline to day 7
Secondary Outcomes (3)
Variation in Breath Delta Value from day 0 to day 1 of parenteral nutrition
day 0 to day 1
Subjects and Variation in Breath Delta Value
baseline to day 7
Variation in Breath Delta Value when Parenteral Nutrition is interrupted
baseline to day 7
Study Arms (1)
Patients receiving intravenous nutrition
Patients will blow into a bag that will capture 500 mL of their exhaled air daily for 7 days or the length of the parenteral nutrition, whichever is shorter. The Isomark Canary will analyze the air to generate a breath delta value.
Interventions
The Isomark Canary will analyze the exhaled air and generate a breath delta value.
Eligibility Criteria
Adult patients (age 18 or order) with clinical indications for parenteral nutrition who are moderately to severely malnourished due to little to no nutrition by other means (oral nutrition or nutrition per tube) for a period of time (0-10 days based on state of nourishment prior to admission).
You may qualify if:
- years of age or older
- Anticipated start of parenteral nutrition
- Expected duration of stay at least 5 days from enrollment
- Subject speaks English
- Subjects with inability to take adequate oral nutrition who are developing or have developed malnutrition who require parenteral nutrition
You may not qualify if:
- Subjects unable to coordinate well enough to give a 1 liter breath sample
- Subjects receiving parenteral nutrition prior to admission
- Subjects who are pregnant
- Subjects who are prisoners
- Subjects who are pharmacologically sedated or with altered consciousness
- Subjects who are mechanically ventilated
- Subjects admitted for bone marrow or stem cell transplants
- Known participation in another interventional research study within 30 days prior to enrollment (note: to be eligible, any interventional treatment must have ended at least 30 days ago)
- Subjects with disease states or clinical conditions that do not make them study candidates, per the primary investigator's discretion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wisconsin, Madisonlead
- Isomark, LLCcollaborator
Study Sites (1)
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53792, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth A Kudsk, MD
University of Wisconsin, Madison
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2016
First Posted
July 25, 2016
Study Start
June 8, 2016
Primary Completion
July 10, 2017
Study Completion
July 10, 2017
Last Updated
November 28, 2017
Record last verified: 2017-11